Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Anyone get results with Ru58841?

      in Treatment  6 upvotes 3 months ago
      RU58841 stopped shedding after two weeks and improved hair after eight months. Initial thinning may occur within the first month.

      community M19 shed after 1yr on dutasteride

      in Finasteride/Dutasteride  23 upvotes 1 year ago
      A 19-year-old male experienced hair shedding after one year on dutasteride and is considering adding topical minoxidil despite scalp itching. Users suggest continuing dutasteride, maintaining a consistent hair routine, and possibly increasing minoxidil dosage.

      community Quote from Pelage (PP-405) Spokesperson...

      in Research/Science  122 upvotes 8 months ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

      community Best places to get clobetasol?

      in Product  1 upvotes 1 year ago
      The user is considering switching to oral dutasteride, topical minoxidil, retinoic acid, and clobetasol for hair loss treatment, after limited regrowth with finasteride and other topicals. They are seeking a source for clobetasol, as they believe it may help with their condition.

      community Starting topical DUT soon!

      in Finasteride/Dutasteride  4 upvotes 5 years ago
      An 18-year-old male stopped using finasteride due to side effects and plans to start topical dutasteride, considering it a potential solution with fewer side effects. He continues using minoxidil despite no noticeable results and is exploring other treatments like RU58841.

      community CRISPR treatment for AGA on the horizon after approval for blood disorders

      in Treatment  9 upvotes 2 years ago
      CRISPR treatments for blood disorders have been approved, leading to discussions about its potential for treating hair loss (AGA). A study showed that editing a gene related to DHT sensitivity could lead to hair regrowth, suggesting CRISPR may eventually be used for AGA, but it's expected to be expensive and not soon available.